Clinical Experience with the Utilization of Dimethyl Fumarate in Patients with Relapsing MS: 5-year Results on Discontinuation and Treatment Outcomes

Authors

• Kyle E Smoot, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Chiayi Chen, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• tamela stuchiner, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Lindsay Lucas, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Lois Grote, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Meghan C Romba, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Elisabeth Lucassen, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Kiren Kresa-Reahl, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow
• Stanley Cohan, Providence Brain & Spine Institute, Providence Health & Services, Portland, Oregon, USAFollow

Document Type

Article

Publication Date

2019

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences